The AstraZeneca/COVISHIELD vaccine doses will primarily be used to provide COVID-19 vaccines in doctors’ offices and pharmacies. Manitoba public health officials have developed guidance for the use of the AstraZeneca/Covishield vaccine. This information is being shared with providers and posted online to guide how appointments are booked once the vaccine is available in Manitoba clinics and pharmacies.
As part of the piloted roll-out of the AstraZeneca/Covishield, Manitobans aged 50 to 64 years (First Nations people aged 30 to 64) with a high-risk condition will be the first group eligible to receive the AstraZeneca/Covishield COVID-19 vaccine. These individuals are at increased risk of experiencing serious illness requiring hospitalization or death related to COVID-19.
Anyone who is ALREADY eligible for the Pfizer/Moderna COVID-19 vaccine (such as health care workers) and is aged 18 to 64 is also eligible to receive AstraZeneca/ Covishield COVID-19 vaccine.
However, anyone who has already received a dose of the Pfizer or Moderna mRNA vaccines must use the same product for their second dose, and should not receive the AstraZeneca/Covishield vaccine.
People with high-risk conditions (as determined by their doctor or pharmacist) will be prioritized, with those who have a condition in Priority List 1 being offered immunization before those with a condition in Priority List 2.
Priority List 1:
Priority List 2: